Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

20.10.2004


St. Jude/Johns Hopkins discovery suggests that manipulating levels of Lag-3 protein on T regulatory cells might prevent autoimmune diseases or amplify immune system attacks on cancer cells



The discovery that the Lag-3 gene acts as a brake to prevent immune system responses from running out of control solves a mystery that has puzzled researchers since the gene was discovered 14 years ago. A report on this discovery, from investigators at St. Jude Children’s Research Hospital and The Johns Hopkins Kimmel Cancer Center, is published in the October issue of the journal Immunity. The researchers solved the mystery of what Lag-3 does by showing that the gene permits so-called regulatory T cells to act as brakes on the immune system.

Regulatory T cells, which carry the Lag-3 protein on their surfaces, interfere with the action of effector T cells--the "warrior" cells that orchestrate attacks on specific targets in the body, such as cancer cells and microorganisms.


The finding could form the basis for new strategies for improving the efficacy of anti-cancer vaccines or preventing autoimmune diseases. Autoimmune diseases are those in which the immune system attacks specific tissues of a person’s own body as if they were foreign matter. The researchers showed that the ability of regulatory T cells to control an attack by effector T cells is substantially prevented or eliminated in the absence of Lag-3.

Both the effector and regulatory cells arise from the same populations of cells, called CD4+ T lymphocytes, according to Dario A. A. Vignali, Ph.D., associate member of St. Jude Immunology. Vignali is senior author of the Immunity report.

The Lag-3 gene is activated in some of the CD4+ cells during an immune system response, turning them into regulatory cells that put the brakes on the activity of their fellow CD4+ T cells that are launching the attack. "The braking action of regulatory T cells prevents the destructive effects of autoimmune diseases, such as diabetes type 1, which occurs when effector T cells mount an attack on the cells of the pancreas that produce insulin," Vignali said.

However, regulatory T cells can also block the beneficial activity of anti-tumor effector cells. This braking action could inhibit an immune system attack on cancer cells. "This study adds to the mounting evidence that regulatory T cells play a major role in dampening the immune system’s anti-tumor activity," said Charles Drake, M.D., Ph.D., assistant professor of Oncology at the Johns Hopkins Kimmel Cancer Center. "The identification of a specific molecule on the surface of these cells that we can block represents an exciting new opportunity to amplify the potency of immune-system-based cancer therapies. We’re actively pursuing the best strategy to test these findings in patients."

Drake is co-author of the paper.

In mouse studies, the researchers first showed that regulatory T cells can protect against a potentially lethal, large-scale immune system attack by effector T cells that ordinarily would have caused a fatal lung disease.

Next, the team used a technique called DNA array analysis to identify which genes in the CD4+ T cells are activated in cells that develop into regulatory T cells. The investigators found that the Lag-3 gene was "expressed" (being used by the cell to make protein) to a much greater extent in regulatory T cells than in effector T cells. The team then showed that inserting the Lag-3 gene into CD4+ T cells turned them into regulatory T cells. These newly minted regulatory T cells suppressed effector T cell activity.

In addition, the researchers showed that antibodies against the Lag-3 protein block this moderating effect of regulatory T cells on the effector T cells, allowing the effector cells to continue an aggressive attack. This finding provided further evidence that Lag-3 is a key protein on regulatory T cells that controls effector T cell function.

"The tumor-specific T cells generated by some anti-cancer vaccines are not very effective because regulatory T cells block their therapeutic activity," said Creg J. Workman, Ph.D., a postdoctoral researcher in Vignali’s lab and co-author of the paper. "But if researchers could block Lag-3 on regulatory T cells it might possible to free such vaccines to generate an especially aggressive attack on cancer cells." "We’d like to put that kind of control over immune function into the hands of physicians," Vignali said.

Bonnie Cameron | EurekAlert!
Further information:
http://www.stjude.org

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>